Previous close | 1.1400 |
Open | 1.1400 |
Bid | 0.7000 |
Ask | 1.0500 |
Strike | 52.50 |
Expiry date | 2026-01-16 |
Day's range | 1.1400 - 1.1400 |
Contract range | N/A |
Volume | |
Open interest | 135 |
Glaukos announces positive second Phase 3 confirmatory pivotal trial for Epioxa.
ARAY's solid product demand and revenue growth raise optimism about the stock.
Bruker announces the formation of the new Bruker Spatial Biology division.